License distinctions, lab-testing requirements & distributor rules: See what California has in store for 2018.
Quality cannabis concentrates should retain natural terpenes, not commercially available terpenes.
The FDA sent warning letters to four companies making unsubstantiated claims about therapeutic benefits of their CBD products.
Spot-checking with potency testing at commercial grow sites is becoming a growing trend, here are some instruments designed for it.
Potency and homogeneity testing for medical concentrates and infused products will be required November 1st.
A lawsuit where a biotech company tries to defend their proprietary extracting technology could set an important new precedent.
We sit down with Josh Drayton, deputy director of the CCIA, to chat about the upcoming changes in the CA cannabis regulatory environment.
The Cannabis Science Conference began with an all-day education event at Chalice Farms’ facility in Portland.
Lagunitas, now owned by Heineken, introduced a cannabis-infused IPA, called “Supercritical.”
In this Op-Ed, Dr. Markus Roggen busts some myths about the ‘Clear’ craze.
